News

Company News: Anergis to Present New COP Allergy Vaccine Data at EAACI Conference 2014 in Copenhagen

– Four scientific communications scheduled for June 8, 9 and 10, 2014 –

Anergis, a company discovering and developing proprietary allergy vaccines, today announced it will present four scientific communications on its Contiguous Overlapping Peptides (COP) allergy vaccines at this year’s European Academy of  Allergy and Clinical Immunology Congress 2014 (EAACI) in Copenhagen, Denmark. The presentations focus on Anergis´ lead compound AllerT against birch pollen allergies, its house dust mite vaccine candidate AllerDM, and a general economic evaluation of allergen immunotherapy for seasonal allergies.

The following scientific communications will be presented at the EAACI Conference 2014:

Presentation Title:AllerT™, Safety and efficacy of a birch pollen allergy vaccine based on contiguous overlapping peptides in a phase IIb study”

Presenter: Prof. Dr. Marek Jutel

Time and Date: Sunday, June 8, 2014, at 03:30pm CET

Session: Oral Abstract Session OAS12: Novel Vaccines for AIT

Abstract #: 481

 

Presentation Title:Development of a hypoallergenic formulation for immunotherapy against house dust mite allergy based on Contiguous Overlapping Peptides”

Presenter: Dr. Alexander Kettner

Time and Date: Monday, June 9, 2014, at 03:45pm CET

Session: Poster Discussion Session PDS 12: AIT Mechanisms

Abstract #: 347

 

Presentation Title: “Effect of AllerT™ ultra-fast immunotherapy on Bet v 1 specific IgG4 and IgE levels; results from a phase IIb study”

Presenter: Prof. Dr. Christophe Reymond

Time and Date: Monday, June 9, 2014, at 03:45pm CET

Session: Poster Discussion Session PDS 12: AIT Mechanisms

Abstract #: 559

 

Presentation Title:Economic evaluation of allergen immunotherapy for seasonal allergic rhinitis”

Presenter: Jean-Paul Rohmer

Time and Date: Tuesday, June 10, 2014, at 12:00pm CET

Session: Thematic Poster Session TPS64: Immunotherapy – AIT Clinics IV

Abstract #: 1411